[Evgeniya46]

вот еще ссылка ин форума на это исследование.
https://healthunlocked.com/cllsupport/posts/137779257/bgb-3111-vs.-br
пишут, что, вроде, неплохая вещь.
вот отзывы их участников:

I have been on BGB-3111 for more than two years (after getting very little relief from a chlorambucil-obinutuzumab trial in 2015, no doubt because I have 17p deletion). BGB has worked well for me. My lymph nodes disappeared in a few months and my lymphocyte count has steadily decreased to a whisker above normal in the past three months. The haematologist told me yesterday that none of the 40 patients in this New Zealand arm of the trial have progressed yet (although some will not have been on it as long as me). The most common side effect is spontaneous bruising, he said, although I have had crippling fatigue that is only beginning to lift now. (He also said I was the only one with fatigue.) It seems to be a very good drug that achieves higher concentrations in the blood than Ibrutinib with less toxicity and fewer side effects, but it also doesn't have as long a track record as Ibrutinib yet. The haematologist spoke very highly of it as an option.

если в 2-х словах, то эффект - меньшая токсичность, в целом меньше побочки, чем у ибрутиниба. Его гемотолог хорошего мнения о препарате как отличном от ибрутиниба варианте.


http://clinical-trials.ru/info_trial/412460.html
это регистрация исследования в рф